JIR
RGEN icon

James Investment Research’s Repligen RGEN Stock Holding History

James Investment Research’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-81,750
Closed -$1.86M – 535
2014
Q2 		$1.86M Hold
81,750
– – 0.06% 177
2014
Q1 		$1.05M Buy
+81,750
New +$1.17M 0.03% 221

Other funds holding RGEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

James Investment Research's RGEN Position: Q3 2014 in Review

James Investment Research sold out of Repligen (RGEN) in Q3 2014, closing a stake of 81,750 shares — an estimated $1.86M sold.

James Investment Research first reported a position in RGEN in Q1 2014 and held it in 2 quarters. The position peaked at $1.86M in Q2 2014. 164 funds tracked by Wall St. Rank hold RGEN as of Q3 2014.

  • James Investment Research reported no remaining Repligen position as of Q3 2014 after selling out during the quarter.
  • James Investment Research sold 81,750 Repligen shares in Q3 2014, an estimated $1.86M.
  • James Investment Research first reported a position in Repligen in Q1 2014 and held it in 2 quarters.
  • James Investment Research's Repligen position peaked at $1.86M in Q2 2014.
  • 164 funds tracked by Wall St. Rank held Repligen as of Q3 2014.

Based on James Investment Research's 13F filing for Q3 2014, filed 9 Oct 2014.